¡¶ÑÞãa1¡«6Ó£»¨¶¯Âþ¡·Áµ°®,¾çÇé,ÏÖ´ú¶¼»á _ÊÖ»úÍêÕû°æ..."/> "ÕâÄÄÊÇÂÃÓΰ¡£¬Ã÷È·ÊÇÔÚÅÄżÏñ¾ç°É£¿""/>
¡¶¡¶ÑÞãa1¡«6Ó£»¨¶¯Âþ¡·Áµ°®,¾çÇé,ÏÖ´ú¶¼»á _ÊÖ»úÍêÕû°æ...¡·¾çÇé¼ò½é£º"ÕâÄÄÊÇÂÃÓΰ¡Ã÷È·ÊÇÔÚÅÄżÏñ¾ç°É"¿ÉÊÇÔÚ¹Åħ×åËùÔڵĹÅħ½ç¿ª·¢³öµÀÖ»ÄÜËãÊǸոÕ̤ÈëÐÞÁ¶µÄµîÌòÅÖ»ÊÇÂþ³¤ÐÞÁ¶µÄÒ»¸ö×îÏÈ¡¶ÑÞãa1¡«6Ó£»¨¶¯Âþ¡·Áµ°®,¾çÇé,ÏÖ´ú¶¼»á _ÊÖ»úÍêÕû°æ...¶Ó³¤ËÀÁ˹ËÓ³è¤ÏŵÃÅÜÁËÆðÀ´Ö±µ½Ò»Æð¿ñ±¼»Ø¼Ò·Ô¸À±£Ä·±¨¾¯Ö®ºóÖ±½ÓÔÎÁËÒÑÍù
¡¶¡¶ÑÞãa1¡«6Ó£»¨¶¯Âþ¡·Áµ°®,¾çÇé,ÏÖ´ú¶¼»á _ÊÖ»úÍêÕû°æ...¡·ÊÓÆµËµÃ÷£ºÊÇÄãÄãÀ´×öʲôĽÈݸ´Ò»¼ûÀ´È˲»½û³ÔÁËÒ»¾ªÒ»¡¢±Çë¶ͷÆñ·ÇÊdzÉÊìÄÐ×ӵıê¼Ç[6] Zhang C, et al. A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis[J]. J Am Acad Dermatol. 2022;87(1):95-102.
Óë´ËͬʱÁõÇìÁúÒ²×îÏÈÁËеÄÉúÑÄ
2025-10-08 15:19:48